Maximum Dose of Cyclosporine for Psoriasis
The maximum recommended dose of cyclosporine for psoriasis is 5 mg/kg/day, with treatment duration typically limited to 12-16 weeks for initial courses and up to 1 year for total cumulative treatment. 1, 2
Dosing Regimen
There are two main approaches to cyclosporine dosing in psoriasis:
Starting at intermediate dose and titrating up:
Starting at maximum dose and tapering down:
- Begin with 5 mg/kg/day (for more severe disease)
- After adequate disease control is achieved, implement stepwise decreases
- Gradually reduce to the lowest effective maintenance dose 3
Efficacy Based on Dosing
- 5 mg/kg/day: Produces PASI 75 response in 50-97% of patients 1, 4
- 3 mg/kg/day: Achieves PASI 75 in 50-70% and PASI 90 in 30-50% of patients 1
- 2.5 mg/kg/day: Achieves PASI 75 in 28-85% of patients 1, 4
Administration Guidelines
- Administer at a consistent time of day and in relation to meals to decrease blood level variations
- Can be mixed with milk, orange juice, or apple juice (avoid grapefruit juice as it increases cyclosporine concentrations) 2
- For maintenance therapy, 3 mg/kg/day has been shown to adequately maintain remission in 58% of patients for 6 months 5
Monitoring and Dose Adjustments
- Monitor serum creatinine monthly
- If serum creatinine increases >25% above baseline on two occasions (separated by 2 weeks):
- Reduce dose by 25-50%
- Follow creatinine every other week for 1 month
- If creatinine doesn't decrease to within 25% of baseline, reduce dose by another 25-50%
- If creatinine remains >25% above baseline after these adjustments, discontinue cyclosporine 3
Duration of Treatment
- Short-term treatment (12-16 weeks) is preferred for initial courses 1
- Continuous treatment beyond 1 year is not recommended due to increased risk of nephrotoxicity 2
- Intermittent short courses are preferred over continuous long-term therapy 3
Important Cautions
- Nephrotoxicity risk: 19-24% develop reversible nephrotoxicity during short-term treatment; >50% of patients treated for >2 years may experience creatinine increases >30% above baseline 1, 4
- Age-related risk: Patients >45 years have higher risk of hypertension and renal function changes 6
- Drug interactions: Avoid concomitant use with aminoglycosides, amphotericin, trimethoprim, ketoconazole, phenytoin, rifampicin, isoniazid, and NSAIDs 7
- Contraindications: Simultaneous administration with NB-UVB phototherapy is contraindicated due to increased photocarcinogenesis risk 1
Common Pitfalls to Avoid
- Exceeding maximum dose: Never exceed 5 mg/kg/day, even in severe cases
- Prolonged continuous treatment: Avoid continuous treatment beyond 1 year
- Inadequate monitoring: Regular monitoring of blood pressure and renal function is essential
- Ignoring drug interactions: Always review medication lists before initiating therapy
- Abrupt discontinuation: Consider gradual tapering to minimize risk of rebound
By following these guidelines, you can maximize the efficacy of cyclosporine while minimizing its potential toxicity in patients with psoriasis.